000078 Stock Overview
Shenzhen Neptunus Bioengineering Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shenzhen Neptunus Bioengineering Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.50 |
| 52 Week High | CN¥3.40 |
| 52 Week Low | CN¥2.01 |
| Beta | 0.38 |
| 1 Month Change | -18.30% |
| 3 Month Change | 1.63% |
| 1 Year Change | -22.60% |
| 3 Year Change | -29.18% |
| 5 Year Change | -31.51% |
| Change since IPO | -63.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000078 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.0% | -4.7% | -4.0% |
| 1Y | -22.6% | -13.7% | 6.4% |
Return vs Industry: 000078 underperformed the CN Healthcare industry which returned -12.9% over the past year.
Return vs Market: 000078 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 000078 volatility | |
|---|---|
| 000078 Average Weekly Movement | 7.1% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 000078 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000078's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 9,093 | Feng Zhang | www.neptunusbio.com |
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine tablets, chlorpheniramine maleate tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work. It also distributes drugs, medical devices, and other medical supplies; and provides value-added services for hospitals, medical institutions, and drug retail institutions and distributors.
Shenzhen Neptunus Bioengineering Co., Ltd. Fundamentals Summary
| 000078 fundamental statistics | |
|---|---|
| Market cap | CN¥6.58b |
| Earnings (TTM) | -CN¥1.73b |
| Revenue (TTM) | CN¥32.33b |
0.2x
P/S Ratio-3.8x
P/E RatioIs 000078 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000078 income statement (TTM) | |
|---|---|
| Revenue | CN¥32.33b |
| Cost of Revenue | CN¥29.34b |
| Gross Profit | CN¥2.99b |
| Other Expenses | CN¥4.72b |
| Earnings | -CN¥1.73b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 29, 2025
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 9.26% |
| Net Profit Margin | -5.36% |
| Debt/Equity Ratio | 261.4% |
How did 000078 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/07 07:22 |
| End of Day Share Price | 2025/01/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shenzhen Neptunus Bioengineering Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhouyu Deng | BOCI Research Ltd. |
| Zhouyu Deng | Guosen Securities Co., Ltd. |